The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Small Nucleic Acid-Based Drug Market Research Report 2024
Synopsis
The global Small Nucleic Acid-Based Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Small Nucleic Acid-Based Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Nucleic Acid-Based Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Nucleic Acid-Based Drug in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Nucleic Acid-Based Drug include Biogen, Pfizer, Jazz, Sarepta Therapeutics, Alnylam, Novartis, Nippon Shinyaku and Swedish Orphan Biovitrum, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Nucleic Acid-Based Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Nucleic Acid-Based Drug.
Report Scope
The Small Nucleic Acid-Based Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Nucleic Acid-Based Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Nucleic Acid-Based Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biogen
Pfizer
Jazz
Sarepta Therapeutics
Alnylam
Novartis
Nippon Shinyaku
Swedish Orphan Biovitrum
Segment by Type
siRNA
Antisense Oligonucleotides
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Nucleic Acid-Based Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Small Nucleic Acid-Based Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Small Nucleic Acid-Based Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Nucleic Acid-Based Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Nucleic Acid-Based Drug in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Nucleic Acid-Based Drug include Biogen, Pfizer, Jazz, Sarepta Therapeutics, Alnylam, Novartis, Nippon Shinyaku and Swedish Orphan Biovitrum, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Nucleic Acid-Based Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Nucleic Acid-Based Drug.
Report Scope
The Small Nucleic Acid-Based Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Nucleic Acid-Based Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Nucleic Acid-Based Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biogen
Pfizer
Jazz
Sarepta Therapeutics
Alnylam
Novartis
Nippon Shinyaku
Swedish Orphan Biovitrum
Segment by Type
siRNA
Antisense Oligonucleotides
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Nucleic Acid-Based Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Nucleic Acid-Based Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 siRNA
1.2.3 Antisense Oligonucleotides
1.3 Market by Application
1.3.1 Global Small Nucleic Acid-Based Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Nucleic Acid-Based Drug Market Perspective (2019-2030)
2.2 Small Nucleic Acid-Based Drug Growth Trends by Region
2.2.1 Global Small Nucleic Acid-Based Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Small Nucleic Acid-Based Drug Historic Market Size by Region (2019-2024)
2.2.3 Small Nucleic Acid-Based Drug Forecasted Market Size by Region (2025-2030)
2.3 Small Nucleic Acid-Based Drug Market Dynamics
2.3.1 Small Nucleic Acid-Based Drug Industry Trends
2.3.2 Small Nucleic Acid-Based Drug Market Drivers
2.3.3 Small Nucleic Acid-Based Drug Market Challenges
2.3.4 Small Nucleic Acid-Based Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Nucleic Acid-Based Drug Players by Revenue
3.1.1 Global Top Small Nucleic Acid-Based Drug Players by Revenue (2019-2024)
3.1.2 Global Small Nucleic Acid-Based Drug Revenue Market Share by Players (2019-2024)
3.2 Global Small Nucleic Acid-Based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Nucleic Acid-Based Drug Revenue
3.4 Global Small Nucleic Acid-Based Drug Market Concentration Ratio
3.4.1 Global Small Nucleic Acid-Based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Nucleic Acid-Based Drug Revenue in 2023
3.5 Small Nucleic Acid-Based Drug Key Players Head office and Area Served
3.6 Key Players Small Nucleic Acid-Based Drug Product Solution and Service
3.7 Date of Enter into Small Nucleic Acid-Based Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Nucleic Acid-Based Drug Breakdown Data by Type
4.1 Global Small Nucleic Acid-Based Drug Historic Market Size by Type (2019-2024)
4.2 Global Small Nucleic Acid-Based Drug Forecasted Market Size by Type (2025-2030)
5 Small Nucleic Acid-Based Drug Breakdown Data by Application
5.1 Global Small Nucleic Acid-Based Drug Historic Market Size by Application (2019-2024)
5.2 Global Small Nucleic Acid-Based Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Small Nucleic Acid-Based Drug Market Size (2019-2030)
6.2 North America Small Nucleic Acid-Based Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Small Nucleic Acid-Based Drug Market Size by Country (2019-2024)
6.4 North America Small Nucleic Acid-Based Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Nucleic Acid-Based Drug Market Size (2019-2030)
7.2 Europe Small Nucleic Acid-Based Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Small Nucleic Acid-Based Drug Market Size by Country (2019-2024)
7.4 Europe Small Nucleic Acid-Based Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Nucleic Acid-Based Drug Market Size (2019-2030)
8.2 Asia-Pacific Small Nucleic Acid-Based Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Small Nucleic Acid-Based Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Small Nucleic Acid-Based Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Nucleic Acid-Based Drug Market Size (2019-2030)
9.2 Latin America Small Nucleic Acid-Based Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Small Nucleic Acid-Based Drug Market Size by Country (2019-2024)
9.4 Latin America Small Nucleic Acid-Based Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Nucleic Acid-Based Drug Market Size (2019-2030)
10.2 Middle East & Africa Small Nucleic Acid-Based Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Small Nucleic Acid-Based Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Small Nucleic Acid-Based Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Small Nucleic Acid-Based Drug Introduction
11.1.4 Biogen Revenue in Small Nucleic Acid-Based Drug Business (2019-2024)
11.1.5 Biogen Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Small Nucleic Acid-Based Drug Introduction
11.2.4 Pfizer Revenue in Small Nucleic Acid-Based Drug Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Jazz
11.3.1 Jazz Company Detail
11.3.2 Jazz Business Overview
11.3.3 Jazz Small Nucleic Acid-Based Drug Introduction
11.3.4 Jazz Revenue in Small Nucleic Acid-Based Drug Business (2019-2024)
11.3.5 Jazz Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Small Nucleic Acid-Based Drug Introduction
11.4.4 Sarepta Therapeutics Revenue in Small Nucleic Acid-Based Drug Business (2019-2024)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam
11.5.1 Alnylam Company Detail
11.5.2 Alnylam Business Overview
11.5.3 Alnylam Small Nucleic Acid-Based Drug Introduction
11.5.4 Alnylam Revenue in Small Nucleic Acid-Based Drug Business (2019-2024)
11.5.5 Alnylam Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Small Nucleic Acid-Based Drug Introduction
11.6.4 Novartis Revenue in Small Nucleic Acid-Based Drug Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 Nippon Shinyaku
11.7.1 Nippon Shinyaku Company Detail
11.7.2 Nippon Shinyaku Business Overview
11.7.3 Nippon Shinyaku Small Nucleic Acid-Based Drug Introduction
11.7.4 Nippon Shinyaku Revenue in Small Nucleic Acid-Based Drug Business (2019-2024)
11.7.5 Nippon Shinyaku Recent Development
11.8 Swedish Orphan Biovitrum
11.8.1 Swedish Orphan Biovitrum Company Detail
11.8.2 Swedish Orphan Biovitrum Business Overview
11.8.3 Swedish Orphan Biovitrum Small Nucleic Acid-Based Drug Introduction
11.8.4 Swedish Orphan Biovitrum Revenue in Small Nucleic Acid-Based Drug Business (2019-2024)
11.8.5 Swedish Orphan Biovitrum Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Small Nucleic Acid-Based Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of siRNA
Table 3. Key Players of Antisense Oligonucleotides
Table 4. Global Small Nucleic Acid-Based Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Small Nucleic Acid-Based Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Small Nucleic Acid-Based Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Small Nucleic Acid-Based Drug Market Share by Region (2019-2024)
Table 8. Global Small Nucleic Acid-Based Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Small Nucleic Acid-Based Drug Market Share by Region (2025-2030)
Table 10. Small Nucleic Acid-Based Drug Market Trends
Table 11. Small Nucleic Acid-Based Drug Market Drivers
Table 12. Small Nucleic Acid-Based Drug Market Challenges
Table 13. Small Nucleic Acid-Based Drug Market Restraints
Table 14. Global Small Nucleic Acid-Based Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Small Nucleic Acid-Based Drug Market Share by Players (2019-2024)
Table 16. Global Top Small Nucleic Acid-Based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Nucleic Acid-Based Drug as of 2023)
Table 17. Ranking of Global Top Small Nucleic Acid-Based Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Small Nucleic Acid-Based Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Small Nucleic Acid-Based Drug Product Solution and Service
Table 21. Date of Enter into Small Nucleic Acid-Based Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Nucleic Acid-Based Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Small Nucleic Acid-Based Drug Revenue Market Share by Type (2019-2024)
Table 25. Global Small Nucleic Acid-Based Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Small Nucleic Acid-Based Drug Revenue Market Share by Type (2025-2030)
Table 27. Global Small Nucleic Acid-Based Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Small Nucleic Acid-Based Drug Revenue Market Share by Application (2019-2024)
Table 29. Global Small Nucleic Acid-Based Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Small Nucleic Acid-Based Drug Revenue Market Share by Application (2025-2030)
Table 31. North America Small Nucleic Acid-Based Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Small Nucleic Acid-Based Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Small Nucleic Acid-Based Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Small Nucleic Acid-Based Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Small Nucleic Acid-Based Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Small Nucleic Acid-Based Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Small Nucleic Acid-Based Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Small Nucleic Acid-Based Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Small Nucleic Acid-Based Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Small Nucleic Acid-Based Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Small Nucleic Acid-Based Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Small Nucleic Acid-Based Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Small Nucleic Acid-Based Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Small Nucleic Acid-Based Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Small Nucleic Acid-Based Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Small Nucleic Acid-Based Drug Product
Table 49. Biogen Revenue in Small Nucleic Acid-Based Drug Business (2019-2024) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Small Nucleic Acid-Based Drug Product
Table 54. Pfizer Revenue in Small Nucleic Acid-Based Drug Business (2019-2024) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Jazz Company Detail
Table 57. Jazz Business Overview
Table 58. Jazz Small Nucleic Acid-Based Drug Product
Table 59. Jazz Revenue in Small Nucleic Acid-Based Drug Business (2019-2024) & (US$ Million)
Table 60. Jazz Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Small Nucleic Acid-Based Drug Product
Table 64. Sarepta Therapeutics Revenue in Small Nucleic Acid-Based Drug Business (2019-2024) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Company Detail
Table 67. Alnylam Business Overview
Table 68. Alnylam Small Nucleic Acid-Based Drug Product
Table 69. Alnylam Revenue in Small Nucleic Acid-Based Drug Business (2019-2024) & (US$ Million)
Table 70. Alnylam Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Small Nucleic Acid-Based Drug Product
Table 74. Novartis Revenue in Small Nucleic Acid-Based Drug Business (2019-2024) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Nippon Shinyaku Company Detail
Table 77. Nippon Shinyaku Business Overview
Table 78. Nippon Shinyaku Small Nucleic Acid-Based Drug Product
Table 79. Nippon Shinyaku Revenue in Small Nucleic Acid-Based Drug Business (2019-2024) & (US$ Million)
Table 80. Nippon Shinyaku Recent Development
Table 81. Swedish Orphan Biovitrum Company Detail
Table 82. Swedish Orphan Biovitrum Business Overview
Table 83. Swedish Orphan Biovitrum Small Nucleic Acid-Based Drug Product
Table 84. Swedish Orphan Biovitrum Revenue in Small Nucleic Acid-Based Drug Business (2019-2024) & (US$ Million)
Table 85. Swedish Orphan Biovitrum Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Nucleic Acid-Based Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Small Nucleic Acid-Based Drug Market Share by Type: 2023 VS 2030
Figure 3. siRNA Features
Figure 4. Antisense Oligonucleotides Features
Figure 5. Global Small Nucleic Acid-Based Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Small Nucleic Acid-Based Drug Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Specialty Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Small Nucleic Acid-Based Drug Report Years Considered
Figure 11. Global Small Nucleic Acid-Based Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Small Nucleic Acid-Based Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Small Nucleic Acid-Based Drug Market Share by Region: 2023 VS 2030
Figure 14. Global Small Nucleic Acid-Based Drug Market Share by Players in 2023
Figure 15. Global Top Small Nucleic Acid-Based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Nucleic Acid-Based Drug as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Small Nucleic Acid-Based Drug Revenue in 2023
Figure 17. North America Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Small Nucleic Acid-Based Drug Market Share by Country (2019-2030)
Figure 19. United States Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Small Nucleic Acid-Based Drug Market Share by Country (2019-2030)
Figure 23. Germany Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Small Nucleic Acid-Based Drug Market Share by Region (2019-2030)
Figure 31. China Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Small Nucleic Acid-Based Drug Market Share by Country (2019-2030)
Figure 39. Mexico Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Small Nucleic Acid-Based Drug Market Share by Country (2019-2030)
Figure 43. Turkey Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Small Nucleic Acid-Based Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2019-2024)
Figure 46. Pfizer Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2019-2024)
Figure 47. Jazz Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2019-2024)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2019-2024)
Figure 49. Alnylam Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2019-2024)
Figure 51. Nippon Shinyaku Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2019-2024)
Figure 52. Swedish Orphan Biovitrum Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
